Table 1.
Disease | Complication | One dose (N = 2017) |
Two doses (N = 4115) |
X2 for “Disease” | X2 for “Complications” | ||
---|---|---|---|---|---|---|---|
N | % | N | % | ||||
Cardiovascular diseases | Death | 273 | 13.53 | 114 | 2.77 | 476.613a | 45.848a |
Infected without hospitalization | 214 | 10.61 | 1033 | 25.10 | |||
Infected with hospitalization | 372 | 18.44 | 328 | 7.97 | |||
Respiratory diseases | Death | 412 | 20.43 | 411 | 9.99 | 291.263a | 131.810a |
Infected without hospitalization | 14 | 0.69 | 232 | 5.64 | |||
Infected with hospitalization | 507 | 25.14 | 1739 | 42.26 | |||
Diabetes | Death | 14 | 0.69 | 7 | 0.17 | 57.660a | 330.981a |
Infected without hospitalization | 161 | 7.98 | 247 | 6.00 | |||
Infected with hospitalization | 50 | 2.48 | 4 | 0.10 |
Significant at p < 0.001.